{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:05:25Z","timestamp":1758906325339,"version":"3.44.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1006\/excr.2001.5438","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T15:02:41Z","timestamp":1033916561000},"page":"256-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Expression Level of c-FLIP versus Fas Determines Susceptibility to Fas Ligand-Induced Cell Death in Murine Thymoma EL-4 Cells"],"prefix":"10.1006","volume":"273","author":[{"given":"Takao","family":"Kataoka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph C.","family":"Budd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrg","family":"Tschopp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/excr.2001.5438_RF1","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","article-title":"Death receptors: Signaling and modulation","volume":"281","author":"Ashkenazi","year":"1998","journal-title":"Science"},{"key":"10.1006\/excr.2001.5438_RF2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","article-title":"Apoptosis by death factor","volume":"88","author":"Nagata","year":"1997","journal-title":"Cell"},{"key":"10.1006\/excr.2001.5438_RF3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1074-7613(00)80150-8","article-title":"Autoimmunity as a consequence of retrovirus-mediated expression of c-FLIP in lymphocytes","volume":"11","author":"Van Parijs","year":"1999","journal-title":"Immunity"},{"key":"10.1006\/excr.2001.5438_RF4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1084\/jem.190.7.1033","article-title":"Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein","volume":"190","author":"Medema","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1006\/excr.2001.5438_RF5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.190.7.1025","article-title":"The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors","volume":"190","author":"Djerbi","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1006\/excr.2001.5438_RF6","doi-asserted-by":"crossref","first-page":"10964","DOI":"10.1073\/pnas.96.20.10964","article-title":"Caspase activation: The induced-proximity model","volume":"96","author":"Salvesen","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/excr.2001.5438_RF7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/40657","article-title":"Inhibition of death receptor signals by cellular FLIP","volume":"388","author":"Irmler","year":"1997","journal-title":"Nature"},{"key":"10.1006\/excr.2001.5438_RF8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0952-7915(98)80223-9","article-title":"Inhibition of Fas death signals by FLIPs","volume":"10","author":"Tschopp","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1006\/excr.2001.5438_RF9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.onc.1200848","article-title":"Bcl-2, Bcl-xL and adenovirus protein E1B 19kD are functionally equivalent in their ability to inhibit cell death","volume":"14","author":"Huang","year":"1997","journal-title":"Oncogene"},{"key":"10.1006\/excr.2001.5438_RF10","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.148.4.1274","article-title":"The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen","volume":"148","author":"Watanabe-Fukunaga","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/excr.2001.5438_RF11","first-page":"553","article-title":"Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes","volume":"60","author":"Leverkus","year":"2000","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2001.5438_RF12","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1182\/blood.V95.11.3478","article-title":"Expression of c-FLIPL and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: Inhibition by bisindolylmaleimide","volume":"95","author":"Willems","year":"2000","journal-title":"Blood"},{"key":"10.1006\/excr.2001.5438_RF13","doi-asserted-by":"crossref","first-page":"24357","DOI":"10.1074\/jbc.M000811200","article-title":"Inhibition of death receptor-mediated gene induction by a cycloheximide-sensitive factor occurs at the level or upstream of Fas-associated death domain protein (FADD)","volume":"275","author":"Wajant","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5438_RF14","first-page":"3947","article-title":"Metabolic inhibitors sensitize for CD95 (APO-1\/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression","volume":"60","author":"Fulda","year":"2000","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2001.5438_RF15","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1084\/jem.188.11.2033","article-title":"p53 activates the CD95 (APO-1\/Fas) gene in response to DNA damage by anticancer drugs","volume":"188","author":"M\u00fcller","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1006\/excr.2001.5438_RF16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0092-8674(95)90412-3","article-title":"Tumor suppressor p53 is a direct transcriptional activator of the human bax gene","volume":"80","author":"Miyashita","year":"1995","journal-title":"Cell"},{"key":"10.1006\/excr.2001.5438_RF17","doi-asserted-by":"crossref","first-page":"17225","DOI":"10.1074\/jbc.C900590199","article-title":"Bcl-2 inhibits a Fas-induced conformational change in the Bax N terminus and Bax mitochondrial translocation","volume":"275","author":"Murphy","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5438_RF18","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1074\/jbc.274.3.1541","article-title":"The role of c-FLIP in modulation of CD95-induced apoptosis","volume":"274","author":"Scaffidi","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5438_RF19","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0960-9822(00)00512-1","article-title":"The caspase-8 inhibitor FLIP promotes activation of NF-\u03baB and Erk signaling pathways","volume":"10","author":"Kataoka","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1006\/excr.2001.5438_RF20","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1128\/MCB.21.12.3964-3973.2001","article-title":"NF-\u03baB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling","volume":"21","author":"Kreuz","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2001.5438_RF21","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1128\/MCB.21.16.5299-5305.2001","article-title":"NF-\u03baB signals induce the expression of c-FLIP","volume":"21","author":"Micheau","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1006\/excr.2001.5438_RF22","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.190.11.1679","article-title":"FLICE-inhibitory protein expression during macrophage differentiation confers resistance to Fas-mediated apoptosis","volume":"190","author":"Perlman","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1006\/excr.2001.5438_RF23","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S1074-7613(00)80566-X","article-title":"Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis","volume":"8","author":"Refaeli","year":"1998","journal-title":"Immunity"},{"key":"10.1006\/excr.2001.5438_RF24","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.4049\/jimmunol.162.9.5205","article-title":"Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis","volume":"162","author":"Algeciras-Schimnich","year":"1999","journal-title":"J. Immunol."},{"key":"10.1006\/excr.2001.5438_RF25","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1084\/jem.188.10.1795","article-title":"Mitogen-activated protein kinase kinase antagonized Fas-associated death domain protein-mediated apoptosis by induced FLICE-inhibitory protein expression","volume":"188","author":"Yeh","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1006\/excr.2001.5438_RF26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1521-4141(200001)30:1<155::AID-IMMU155>3.0.CO;2-X","article-title":"Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP","volume":"30","author":"Wang","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/excr.2001.5438_RF27","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.4049\/jimmunol.165.11.6262","article-title":"Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells","volume":"165","author":"Yoshikawa","year":"2000","journal-title":"J. Immunol."},{"key":"10.1006\/excr.2001.5438_RF28","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1002\/j.1460-2075.1995.tb00304.x","article-title":"Bcl-2 and Fas\/APO-1 regulate distinct pathways to lymphocyte apoptosis","volume":"14","author":"Strasser","year":"1995","journal-title":"EMBO J."},{"key":"10.1006\/excr.2001.5438_RF29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.191.1.195","article-title":"Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD\/MORT1 signaling: implications for cancer therapy","volume":"191","author":"Newton","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1006\/excr.2001.5438_RF30","first-page":"1217","article-title":"CD95 (Fas\/APO-1) and p53 signal apoptosis independently in diverse cell types","volume":"60","author":"O' Connor","year":"2000","journal-title":"Cancer Res."},{"key":"10.1006\/excr.2001.5438_RF31","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1074\/jbc.275.6.3867","article-title":"Human and mouse Fas (APO-1\/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis","volume":"275","author":"Munsch","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1006\/excr.2001.5438_RF32","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1038\/sj.onc.1204673","article-title":"Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells","volume":"20","author":"Fukazawa","year":"2001","journal-title":"Oncogene"},{"key":"10.1006\/excr.2001.5438_RF33","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.4049\/jimmunol.161.8.3936","article-title":"FLIP prevents apoptosis induced by death receptors but not by perforin\/granzyme B, chemotherapeutic drugs, and gamma irradiation","volume":"161","author":"Kataoka","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/excr.2001.5438_RF34","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1074-7613(00)80214-9","article-title":"Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development","volume":"12","author":"Yeh","year":"2000","journal-title":"Immunity"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482701954382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482701954382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T03:18:48Z","timestamp":1757992728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482701954382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0014482701954382"],"URL":"https:\/\/doi.org\/10.1006\/excr.2001.5438","relation":{},"ISSN":["0014-4827"],"issn-type":[{"type":"print","value":"0014-4827"}],"subject":[],"published":{"date-parts":[[2002,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression Level of c-FLIP versus Fas Determines Susceptibility to Fas Ligand-Induced Cell Death in Murine Thymoma EL-4 Cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/excr.2001.5438","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Elsevier Science (USA). All rights reserved.","name":"copyright","label":"Copyright"}]}}